The effect of 4-week rehabilitation on heart rate variability and QTc interval in patients with chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 6, 2014, Pages 659-669

  Zupanic, Eva ^a   Zivanovic, Ina ^a   Kalisnik, Jurij Matija ^b   Avbelj, Viktor ^c   Lainscak, Mitja ^d,e  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

^d University Clinic of Pulmonary and Allergic Diseases Golnik   (Slovenia)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chronic obstructive pulmonary disease; Exercise training; Heart rate variability; QT interval; Rehabilitation

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STEROID; VITAMIN D;

6 MIN WALK TEST; ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ELECTROCARDIOGRAPHY; EXPERIMENTAL TEST; FEMALE; HEART RATE VARIABILITY; HUMAN; INCREMENTAL SHUTTLE WALKING TEST; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; QT INTERVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION CARE; ST. GEORGE RESPIRATORY QUESTIONNAIRE; STEROID THERAPY; VITAMIN SUPPLEMENTATION; WALKING; AGED; EXERCISE TEST; HEART RATE; KINESIOTHERAPY; MIDDLE AGED; NORMAL HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

AGED; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; EXERCISE TEST; EXERCISE THERAPY; FEMALE; HEALTHY VOLUNTEERS; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; WALKING;

EID: 84910628277     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.898046     Document Type: Article

References (42)

1. Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada: cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16(1):63-70.
2. Lainscak M, Dagres N, Filippatos GS, et al. Atrial fibrillation in chronic non-cardiac disease: where do we stand? Int J Cardiol 2008; 128(3):311-315.
3. Van Gestel AJ, Steier J. Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD). J Thorac Dis 2010; 2(4):215-222.
4. Andreas S, Anker SD, Scanlon PD, et al. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest 2005; 128(5):3618-3624.
5. Stein PK, Nelson P, Rottman JN, et al. Heart rate variability reflects severity of COPD in PiZ α1-antitrypsin deficiency. Chest 1998; 113(2):327-333.
6. Volterrani M, Scalvini S, Mazzuero G, et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 1994; 106(5):1432-1437.
7. Gunduz H, Talay F, Arinc H, et al. Heart rate variability and heart rate turbulence in patients with chronic obstructive pulmonary disease. Cardiol J 2009; 16(6):553-559.
8. Chen WL, Chen GY, Kuo CD. Hypoxemia and autonomic nervous dysfunction in patients with chronic obstructive pulmonary disease. Respir Med 2006; 100(9): 1547-1553.
9. Van Gestel AJ, Kohler M, Steier J, et al. Cardiac autonomic dysfunction and health-related quality of life in patients with chronic obstructive pulmonary disease. Respirology 2011; 16(6):939-946.
10. Tükek T, Yildiz P, Atilgan D, et al. Effect of diurnal variability of heart rate on development of arrhythmia in patients with chronic obstructive pulmonary disease. Int J Cardiol 2003; 88(2-3):199-206.
11. Stewart AG, Waterhouse JC, Howard P. The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD. Respir Med 1995; 89(2): 79-84.
12. Bones U, Zabret M, Sarc I et al. Electrocardiogram analysis and survival of patients with chronic obstructive pulmonary disease. Chest 2011; 140(4-Meeting abstracts):575A.
13. Sarc I, Jeric T, Ziherl K, et al. Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease. J Eval Clin Pract 2011; 17(4):737-743.
14. Bolton CE, Bevan-Smith EF, Blakey JD, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE. Thorax 2013; 68 Suppl 2:ii1-ii30.
15. Borghi-Silva A, Arena R, Castello V, et al. Aerobic exercise training improves autonomic nervous control in patients with COPD. Respir Med 2009; 103(10):1503-1510.
16. Camillo CA, Laburu Vde M, Gonc¸alves NS, et al. Improvement of heart rate variability after exercise training and its predictors in COPD. Resp Med 2011; 105(7):1054-1062.
17. Ricci-Vitor AL, Bonfim R, Fosco LC, et al. Influence of the resistance training on heart rate variability, functional capacity and muscle strength in the chronic obstructive pulmonary disease. Eur J Phys Rehabil Med 2013; 49(6):793-810.
18. Weippert M, Kumar M, Kreuzfeld S, et al. Comparison of three mobile devices for measuring R-R intervals and heart rate variability: Polar S810i, Suunto t6 and an ambulatory ECG system. Eur J Appl Physiol 2010; 109(4):779-786.
19. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188(8):e13-64.
20. Gloeckl R, Marinov B, Pitta F. Practical recommendations for exercise training in patients with COPD. Eur Respir Rev 2013; 22(128):178-186.
21. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19(3):398-404.
22. Polkey MI, Spruit MA, Edwards LD, et al. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2013; 187(4):382-386.
23. Singh SJ, Jones PW, Evans R, et al. Minimum clinically important improvement for the incremental shuttle walking test. Thorax 2008; 63(9):775-777.
24. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17(3):354-381.
25. Goldberger AL, Amaral LA, Glass L, et al. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation 2000; 101(23):E215-220.
26. Sagie A, Larson MG, Goldberg RJ, et al. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol. 1992; 70(7):797-801.
27. Warnier MJ, Rutten FH, Numans ME, et al. Electrocardiographic characteristics of patients with chronic obstructive pulmonary disease. COPD 2013; 10(1):62-71.
28. Jensen MT, Marott JL, Lange P, et al. Resting heart rate is a predictor of mortality in COPD. Eur Respir J 2013; 42(2):341-349.
29. Eckberg DL. Sympathovagal balance. A critical appraisal. Circulation 1997; 96:3224-3232.
30. Kalisnik JM, Avbelj V, Trobec R, et al. Assessment of cardiac autonomic regulation and ventricular repolarization after off-pump coronary artery bypass grafting. Heart Surg Forum 2006; 9(3):E661-E667.
31. Billman GE. The effect of heart rate on the heart rate variability response to autonomic interventions. Front Physiol 2013; 4:222.
32. Schuit AJ, Dekker JM, de Vegt F, et al. Effect of physical training on QTc interval in elderly people. J Electrocardiol 1998; 31(2):111-116.
33. de Bruyne MC, Hoes AW, Kors JA, et al. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. Eur Heart J 1999; 20(4):278-284.
34. Pinna GD, Maestri R, Torunski A, et al. Heart rate variability measures: a fresh look at reliability. Clin Sci (Lond) 2007; 113(3):131-140.
35. Bartels MN, Jelic S, Gonzalez JM, et al. Reproducibility of heart rate and blood pressure variability in patients with chronic obstructive pulmonary disease. Clin Auton Res 2004; 14(3):194-196.
36. Kobayashi H. Does paced breathing improve the reproducibility of heart rate variability measurements? J Physiol Anthropol 2009; 28(5):225-230.
37. De Meersman RE, Reisman SS, Daum M, et al. Influence of respiration on metabolic, hemodynamic, psychometric, and R-R interval power spectral parameters. Am J Physiol 1995; 269(4 Pt 2):H1437-1440.
38. Sloan RP, Korten JB, Myers MM. Components of heart rate reactivity during mental arithmetic with and without speaking. Physiol Behav 1991; 50(5):1039-1045.
39. Bloomfield DM, Magnano A, Bigger JT Jr, et al. Comparison of spontaneous vs. metronome-guided breathing on assessment of vagal modulation using RR variability. Am J Physiol Heart Circ Physiol 2001; 280(3):H1145-1150.
40. Kontopoulos AG, Athyros VG, Papageorgiou AA, et al. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients. Coron Artery Dis 1997; 8(8-9):517-524.
41. Kontopoulos AG, Athyros VG, Didangelos TP, et al. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 1997; 20(3):355-61.
42. Athyros VG, Didangelos TP, Karamitsos DT, et al. Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy. Acta Cardiol 1998; 53(4):201-209.